• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄病毒属之间的交叉反应性免疫。

Cross-Reactive Immunity Among Flaviviruses.

机构信息

Department of Pathology, Duke University Medical Center, Durham, NC, United States.

Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.

出版信息

Front Immunol. 2020 Feb 26;11:334. doi: 10.3389/fimmu.2020.00334. eCollection 2020.

DOI:10.3389/fimmu.2020.00334
PMID:32174923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7054434/
Abstract

Flaviviruses consist of significant human pathogens responsible for hundreds of millions of infections each year. Their antigenic relationships generate immune responses that are cross-reactive to multiple flaviviruses and their widespread and overlapping geographical distributions, coupled with increases in vaccination coverage, increase the likelihood of exposure to multiple flaviviruses. Depending on the antigenic properties of the viruses to which a person is exposed, flavivirus cross-reactivity can be beneficial or could promote immune pathologies. In this review we describe our knowledge of the functional immune outcomes that arise from varied flaviviral immune statuses. The cross-reactive antibody and T cell immune responses that are protective versus pathological are also addressed.

摘要

黄病毒属包含多种重要的人类病原体,每年导致数亿例感染。其抗原关系产生的免疫反应对多种黄病毒具有交叉反应性,且这些病毒广泛存在且地理分布重叠,再加上疫苗接种覆盖率的增加,增加了接触多种黄病毒的可能性。根据一个人接触的病毒的抗原特性,黄病毒交叉反应性可能是有益的,也可能促进免疫病理。在这篇综述中,我们描述了我们对不同黄病毒免疫状态下产生的功能性免疫结果的了解。还讨论了针对保护性和病理性的交叉反应性抗体和 T 细胞免疫反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acce/7054434/018bd5e5cf85/fimmu-11-00334-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acce/7054434/37744a33652b/fimmu-11-00334-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acce/7054434/018bd5e5cf85/fimmu-11-00334-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acce/7054434/37744a33652b/fimmu-11-00334-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acce/7054434/018bd5e5cf85/fimmu-11-00334-g002.jpg

相似文献

1
Cross-Reactive Immunity Among Flaviviruses.黄病毒属之间的交叉反应性免疫。
Front Immunol. 2020 Feb 26;11:334. doi: 10.3389/fimmu.2020.00334. eCollection 2020.
2
T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.减毒黄病毒疫苗诱导的 T 细胞反应具有特异性,与其他黄病毒种属表现出有限的交叉反应性。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00089-20.
3
Different Cross-Reactivities of IgM Responses in Dengue, Zika and Tick-Borne Encephalitis Virus Infections.登革热、寨卡病毒和蜱传脑炎病毒感染中 IgM 反应的不同交叉反应性。
Viruses. 2021 Mar 31;13(4):596. doi: 10.3390/v13040596.
4
Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.用免疫复合物进行免疫接种可调节针对黄病毒抗原的抗体应答的精细特异性。
J Virol. 2015 Aug;89(15):7970-8. doi: 10.1128/JVI.00938-15. Epub 2015 May 27.
5
The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.人类对黄病毒抗体反应的光明面和黑暗面:对疫苗设计的启示。
EMBO Rep. 2018 Feb;19(2):206-224. doi: 10.15252/embr.201745302. Epub 2017 Dec 27.
6
Mapping the diverse structural landscape of the flavivirus antibody repertoire.绘制黄病毒抗体库的多样化结构景观。
Curr Opin Virol. 2020 Dec;45:51-64. doi: 10.1016/j.coviro.2020.07.006. Epub 2020 Aug 13.
7
Epitope mapping of flavivirus glycoproteins.黄病毒糖蛋白的表位作图
Adv Virus Res. 1986;31:103-68. doi: 10.1016/s0065-3527(08)60263-8.
8
Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine?寨卡病毒和登革热病毒之间的抗原交叉反应:是否是时候开发通用疫苗了?
Curr Opin Immunol. 2019 Aug;59:1-8. doi: 10.1016/j.coi.2019.02.001. Epub 2019 Mar 15.
9
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.抗体介导的黄病毒感染中和作用的分子机制。
Expert Rev Mol Med. 2008 May 12;10:e12. doi: 10.1017/S1462399408000665.
10
CD4 T cell responses to flaviviruses.CD4 T 细胞对黄病毒的反应。
J Clin Virol. 2018 Nov;108:126-131. doi: 10.1016/j.jcv.2018.09.020. Epub 2018 Oct 3.

引用本文的文献

1
Pre-existing YFV-17D immunity mediates T cell cross-protection against dengue virus serotype 2 infection in mice.预先存在的黄热病病毒17D免疫力介导小鼠T细胞对登革病毒2型感染的交叉保护作用。
Commun Biol. 2025 Sep 2;8(1):1334. doi: 10.1038/s42003-025-08793-3.
2
Cellular Immune Response in Horses After West Nile Neuroinvasive Disease.西尼罗河神经侵袭性疾病后马的细胞免疫反应
Animals (Basel). 2025 Aug 11;15(16):2352. doi: 10.3390/ani15162352.
3
Human T Cell Responses to Flavivirus Vaccines.人类T细胞对黄病毒疫苗的反应。

本文引用的文献

1
Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections.异源免疫:在自然和疫苗诱导的抗感染中的作用。
Front Immunol. 2019 Nov 8;10:2631. doi: 10.3389/fimmu.2019.02631. eCollection 2019.
2
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.四价登革热疫苗在健康儿童和青少年中的功效。
N Engl J Med. 2019 Nov 21;381(21):2009-2019. doi: 10.1056/NEJMoa1903869. Epub 2019 Nov 6.
3
Seeking Cross-Protective Immunity.寻求交叉保护免疫。
Eur J Immunol. 2025 Aug;55(8):e70027. doi: 10.1002/eji.70027.
4
Factors determining the outcomes of immune imprinting after repeated orthoflavivirus infections.决定反复感染黄病毒属病毒后免疫印记结果的因素。
Front Immunol. 2025 Jul 16;16:1560851. doi: 10.3389/fimmu.2025.1560851. eCollection 2025.
5
Mosquito- and tick-borne orthoflaviviruses cross an endothelial-astrocyte barrier.蚊媒和蜱媒正黄病毒可穿越内皮细胞-星形胶质细胞屏障。
Front Cell Infect Microbiol. 2025 Jul 2;15:1624636. doi: 10.3389/fcimb.2025.1624636. eCollection 2025.
6
Long-Term Humoral Immune Response After West Nile Virus Convalescence in Horses in a Geographic Area of Multiple Orthoflavivirus Co-Circulation.在多种黄病毒共同传播的地理区域,马匹感染西尼罗河病毒康复后的长期体液免疫反应
J Vet Intern Med. 2025 Jul-Aug;39(4):e70176. doi: 10.1111/jvim.70176.
7
The alarming spread of Japanese encephalitis: A growing public health concern.日本脑炎的惊人传播:日益严重的公共卫生问题。
Open Vet J. 2025 Apr;15(4):1505-1519. doi: 10.5455/OVJ.2025.v15.i4.1. Epub 2025 Apr 30.
8
Safety and Immunogenicity of the Attenuated Yellow Fever Vaccine in Several Neotropical Primate Species.减毒黄热病疫苗在几种新热带灵长类动物中的安全性和免疫原性。
Vaccines (Basel). 2025 Apr 30;13(5):487. doi: 10.3390/vaccines13050487.
9
Serologic Surveillance for Orthoflaviviruses and Chikungunya Virus in Bats and Opossums in Chiapas, Mexico.墨西哥恰帕斯州蝙蝠和负鼠中黄病毒属病毒及基孔肯雅病毒的血清学监测
Viruses. 2025 Apr 22;17(5):590. doi: 10.3390/v17050590.
10
Proceedings of the second annual dengue endgame summit: A call to action.第二届登革热终结峰会会议记录:行动呼吁
PLoS Negl Trop Dis. 2025 Apr 28;19(4):e0013028. doi: 10.1371/journal.pntd.0013028. eCollection 2025 Apr.
Front Immunol. 2019 Sep 20;10:2260. doi: 10.3389/fimmu.2019.02260. eCollection 2019.
4
Oligomeric state of the ZIKV E protein defines protective immune responses.ZIKV E 蛋白的寡聚状态决定了保护性免疫反应。
Nat Commun. 2019 Oct 10;10(1):4606. doi: 10.1038/s41467-019-12677-6.
5
Is Dengvaxia a useful vaccine for dengue endemic areas?登革热疫苗对登革热流行地区有用吗?
BMJ. 2019 Oct 3;367:l5710. doi: 10.1136/bmj.l5710.
6
Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination.先前存在的黄热病免疫力会损害并调节对蜱传脑炎疫苗接种的抗体反应。
NPJ Vaccines. 2019 Sep 6;4:38. doi: 10.1038/s41541-019-0133-5. eCollection 2019.
7
Risk of Zika microcephaly correlates with features of maternal antibodies. Zika 小头畸形的风险与母体抗体的特征相关。
J Exp Med. 2019 Oct 7;216(10):2302-2315. doi: 10.1084/jem.20191061. Epub 2019 Aug 14.
8
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.一种靶向免疫显性 NS 表位的改良 mRNA 疫苗可预防 HLA I 类转基因小鼠感染登革病毒。
Front Immunol. 2019 Jun 21;10:1424. doi: 10.3389/fimmu.2019.01424. eCollection 2019.
9
In-depth characterization of congenital Zika syndrome in immunocompetent mice: Antibody-dependent enhancement and an antiviral peptide therapy.深入分析免疫功能正常的小鼠先天性寨卡综合征的特征:抗体依赖性增强作用和抗病毒肽治疗。
EBioMedicine. 2019 Jun;44:516-529. doi: 10.1016/j.ebiom.2019.05.014. Epub 2019 May 23.
10
Human antibody response to Zika targets type-specific quaternary structure epitopes.人类对寨卡病毒的抗体反应针对的是特定类型的四级结构表位。
JCI Insight. 2019 Apr 18;4(8). doi: 10.1172/jci.insight.124588.